Long-Term Outcomes in Moderate and Severe Aortic Stenosis According to Extent of Cardiac Damage.
Options
BORIS DOI
Publisher DOI
PubMed ID
41161924
Description
Background
Cardiac damage (CD) significantly affects the prognosis of patients with aortic stenosis (AS).Objectives
The aim of this study was to investigate the impact of CD on long-term survival in patients with moderate and severe AS.Methods
In a pooled analysis of 2 single-center registries, patients with moderate or severe AS were included according to the presence of early (stages 0 and 1) or advanced (stages 2-4) CD.Results
Among 1,096 patients with AS included between 2009 and 2023, 626 patients (mean age 78.9 ± 8.0 years, 33.1% women) had moderate (n = 343) or severe AS (n = 283). Advanced CD was present in 497 patients (79.4%), and the median follow-up duration was 7.4 years (Q1-Q3: 4.2-10.6 years). There was a gradual increase in the risk for 10-year mortality from moderate to severe AS and from early CD (moderate AS: reference; severe AS: adjusted HR [aHR]: 1.42; 95% CI: 0.75-2.72) to advanced CD (moderate AS: aHR: 1.91; 95% CI: 1.22-2.97; severe AS: aHR: 2.77; 95% CI: 1.73-4.45). At a median 347 days, 344 patients (54.9%) had undergone aortic valve replacement (AVR). In patients with advanced CD, AVR was associated with lower mortality compared with conservative management, irrespective of AS severity (moderate AS: aHR: 0.43; 95% CI: 0.28-0.66; severe AS: aHR: 0.27; 95% CI: 0.18-0.39). In patients with early CD, AVR was associated with lower mortality in patients with severe AS (aHR: 0.29; 95% CI: 0.10-0.86), but not in those with moderate AS (aHR: 0.61; 95% CI: 0.25-1.44).Conclusions
Ten-year mortality in patients with moderate and severe AS is importantly determined by CD extent. AVR was associated with lower mortality in patients with moderate AS and advanced CD.
Cardiac damage (CD) significantly affects the prognosis of patients with aortic stenosis (AS).Objectives
The aim of this study was to investigate the impact of CD on long-term survival in patients with moderate and severe AS.Methods
In a pooled analysis of 2 single-center registries, patients with moderate or severe AS were included according to the presence of early (stages 0 and 1) or advanced (stages 2-4) CD.Results
Among 1,096 patients with AS included between 2009 and 2023, 626 patients (mean age 78.9 ± 8.0 years, 33.1% women) had moderate (n = 343) or severe AS (n = 283). Advanced CD was present in 497 patients (79.4%), and the median follow-up duration was 7.4 years (Q1-Q3: 4.2-10.6 years). There was a gradual increase in the risk for 10-year mortality from moderate to severe AS and from early CD (moderate AS: reference; severe AS: adjusted HR [aHR]: 1.42; 95% CI: 0.75-2.72) to advanced CD (moderate AS: aHR: 1.91; 95% CI: 1.22-2.97; severe AS: aHR: 2.77; 95% CI: 1.73-4.45). At a median 347 days, 344 patients (54.9%) had undergone aortic valve replacement (AVR). In patients with advanced CD, AVR was associated with lower mortality compared with conservative management, irrespective of AS severity (moderate AS: aHR: 0.43; 95% CI: 0.28-0.66; severe AS: aHR: 0.27; 95% CI: 0.18-0.39). In patients with early CD, AVR was associated with lower mortality in patients with severe AS (aHR: 0.29; 95% CI: 0.10-0.86), but not in those with moderate AS (aHR: 0.61; 95% CI: 0.25-1.44).Conclusions
Ten-year mortality in patients with moderate and severe AS is importantly determined by CD extent. AVR was associated with lower mortality in patients with moderate AS and advanced CD.
Date of Publication
2025-10-27
Publication Type
Article
Subject(s)
Keyword(s)
aortic stenosis
•
aortic valve replacement
•
cardiac damage
Language(s)
en
Contributor(s)
Series
JACC: Cardiovascular Interventions
Publisher
Elsevier
ISSN
1876-7605
1936-8798
Access(Rights)
open.access